BIOQUAL Presents Financial Results for Fiscal Year 2014 and Declares Dividend

ROCKVILLE, Md.--()--BIOQUAL:

       

2014

2013

Revenue $ 21,579,740 $ 20,204,308
 
(Loss) Income Before Income Tax $ 1,495,164 $ (107,016 )
 
Net (Loss) Income $ 868,201 $ (87,244 )
 

Basic (Loss) Earnings per Share of Common Stock

$

.97

$

(.10

)

 

Diluted (Loss) Earnings per Share of Common Stock

$

.97

$

(.10

)

 

Weighted Average Number of Shares Outstanding For Basic Earnings

893,470 894,934
 

Weighted Average Number of Shares Outstanding For Diluted Earnings

893,470 894,934
 

BIOQUAL’s Board of Directors has declared a dividend of $0.20 per share for shareholders of record on November 28, 2014, payable on December 15, 2014. This is the thirteenth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risk and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts and obtain new contracts; the actual cost incurred in performing its contracts; uncertainties relating to clinical trials; dependence on third parties; and future capital needs.

Contacts

BIOQUAL
Mark G. Lewis, Ph.D., CEO
301-251-2801
www.bioqual.com

Recent Stories

RSS feed for BIOQUAL

BIOQUAL